Clinical Trial Update: Retinoblastoma Phase II Expanded Access Clinical Trial [Phase 2]

View source ↗

Summary

Phase II expanded-access clinical trial for retinoblastoma sponsored by Targeted Therapy Technologies, LLC is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinoblastoma

Snippet

Sponsor: Targeted Therapy Technologies, LLC | Conditions: Retinoblastoma | Phase 2 | Status: RECRUITING